These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

789 related articles for article (PubMed ID: 20542038)

  • 1. Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment.
    Pietrangelo A
    Gastroenterology; 2010 Aug; 139(2):393-408, 408.e1-2. PubMed ID: 20542038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetics, Genetic Testing, and Management of Hemochromatosis: 15 Years Since Hepcidin.
    Pietrangelo A
    Gastroenterology; 2015 Oct; 149(5):1240-1251.e4. PubMed ID: 26164493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular pathogenesis of hereditary hemochromatosis.
    Liu J; Pu C; Lang L; Qiao L; Abdullahi MA; Jiang C
    Histol Histopathol; 2016 Aug; 31(8):833-40. PubMed ID: 27031690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic evaluation of hereditary hemochromatosis (HFE and non-HFE).
    Bardou-Jacquet E; Brissot P
    Hematol Oncol Clin North Am; 2014 Aug; 28(4):625-35, v. PubMed ID: 25064704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic iron metabolism gene expression profiles in HFE associated hereditary hemochromatosis.
    Gleeson F; Ryan E; Barrett S; Russell J; Crowe J
    Blood Cells Mol Dis; 2007; 38(1):37-44. PubMed ID: 17098454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hemochromatosis--from an underdiagnosed curiosity to a common disease].
    Hagve TA; Asberg A; Ulvik R; Borch-Iohnsen B; Thorstensen K
    Tidsskr Nor Laegeforen; 2009 Apr; 129(9):863-6. PubMed ID: 19415085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary iron overload with inappropriate hepcidin expression in V162del ferroportin disease.
    Zoller H; McFarlane I; Theurl I; Stadlmann S; Nemeth E; Oxley D; Ganz T; Halsall DJ; Cox TM; Vogel W
    Hepatology; 2005 Aug; 42(2):466-72. PubMed ID: 15986403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differing impact of the deletion of hemochromatosis-associated molecules HFE and transferrin receptor-2 on the iron phenotype of mice lacking bone morphogenetic protein 6 or hemojuvelin.
    Latour C; Besson-Fournier C; Meynard D; Silvestri L; Gourbeyre O; Aguilar-Martinez P; Schmidt PJ; Fleming MD; Roth MP; Coppin H
    Hepatology; 2016 Jan; 63(1):126-37. PubMed ID: 26406355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EASL clinical practice guidelines for HFE hemochromatosis.
    European Association For The Study Of The Liver
    J Hepatol; 2010 Jul; 53(1):3-22. PubMed ID: 20471131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Genetics of hereditary iron overload].
    Le Gall JY; Jouanolle AM; Fergelot P; Mosser J; David V
    Bull Acad Natl Med; 2004; 188(2):247-62; discussion 262-3. PubMed ID: 15506716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early onset hereditary hemochromatosis resulting from a novel TFR2 gene nonsense mutation (R105X) in two siblings of north French descent.
    Le Gac G; Mons F; Jacolot S; Scotet V; Férec C; Frébourg T
    Br J Haematol; 2004 Jun; 125(5):674-8. PubMed ID: 15147384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of genes that may modulate the expression of hereditary hemochromatosis: transferrin receptor-1, ferroportin, ceruloplasmin, ferritin light and heavy chains, iron regulatory proteins (IRP)-1 and -2, and hepcidin.
    Lee PL; Gelbart T; West C; Halloran C; Felitti V; Beutler E
    Blood Cells Mol Dis; 2001; 27(5):783-802. PubMed ID: 11783942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Juvenile hemochromatosis associated with heterozygosity for novel hemojuvelin mutations and with unknown cofactors.
    Pelusi S; Rametta R; Della Corte C; Congia R; Dongiovanni P; Pulixi EA; Fargion S; Fracanzani AL; Nobili V; Valenti L
    Ann Hepatol; 2014; 13(5):568-71. PubMed ID: 25152992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemochromatosis gene mutations, liver function tests and iron status in alcohol-dependent patients admitted for detoxification.
    Robinson G; Narasimhan S; Weatherall M; Beasley R
    J Gastroenterol Hepatol; 2007 Jun; 22(6):852-4. PubMed ID: 17565641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-HFE hepatic iron overload.
    Pietrangelo A; Caleffi A; Corradini E
    Semin Liver Dis; 2011 Aug; 31(3):302-18. PubMed ID: 21901660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemochromatosis (HFE) and transferrin receptor-1 (TFRC1) genes in sporadic porphyria cutanea tarda (sPCT).
    Lamoril J; Andant C; Gouya L; Malonova E; Grandchamp B; Martásek P; Deybac JC; Puy H
    Cell Mol Biol (Noisy-le-grand); 2002 Feb; 48(1):33-41. PubMed ID: 11929045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mechanisms of systemic iron homeostasis and etiology, diagnosis, and treatment of hereditary hemochromatosis.
    Kawabata H
    Int J Hematol; 2018 Jan; 107(1):31-43. PubMed ID: 29134618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HJV and HFE Play Distinct Roles in Regulating Hepcidin.
    Wu Q; Wang H; An P; Tao Y; Deng J; Zhang Z; Shen Y; Chen C; Min J; Wang F
    Antioxid Redox Signal; 2015 May; 22(15):1325-36. PubMed ID: 25608116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TFR2-related hereditary hemochromatosis as a frequent cause of primary iron overload in patients from Central-Southern Italy.
    Radio FC; Majore S; Binni F; Valiante M; Ricerca BM; De Bernardo C; Morrone A; Grammatico P
    Blood Cells Mol Dis; 2014; 52(2-3):83-7. PubMed ID: 24055163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and treatment of hereditary hemochromatosis: an update.
    Kanwar P; Kowdley KV
    Expert Rev Gastroenterol Hepatol; 2013 Aug; 7(6):517-30. PubMed ID: 23985001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.